These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 1646353)
1. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis. Czaja AJ; Taswell HF; Rakela J; Schimek CM Mayo Clin Proc; 1991 Jun; 66(6):572-82. PubMed ID: 1646353 [TBL] [Abstract][Full Text] [Related]
2. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis. Czaja AJ; Taswell HF; Rakela J; Schimek CM Mayo Clin Proc; 1990 Oct; 65(10):1303-13. PubMed ID: 2170781 [TBL] [Abstract][Full Text] [Related]
3. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III. Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329 [TBL] [Abstract][Full Text] [Related]
4. Duration and specificity of antibodies to hepatitis C virus in chronic active hepatitis. Czaja AJ; Taswell HF; Rakela J; Rabe D Gastroenterology; 1992 May; 102(5):1675-9. PubMed ID: 1314751 [TBL] [Abstract][Full Text] [Related]
5. Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis. Czaja AJ; Taswell HF; Rakela J; Schimek C J Hepatol; 1992 Jan; 14(1):88-93. PubMed ID: 1310707 [TBL] [Abstract][Full Text] [Related]
6. Autoimmune chronic active hepatitis: changing reactivity for antibodies to hepatitis C virus after immunosuppressive treatment. Schvarcz R; von Sydow M; Weiland O Scand J Gastroenterol; 1990 Nov; 25(11):1175-80. PubMed ID: 2177220 [TBL] [Abstract][Full Text] [Related]
7. Anti-GOR and hepatitis C virus in autoimmune liver diseases. Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282 [TBL] [Abstract][Full Text] [Related]
8. Is autoimmune chronic active hepatitis a HCV-related disease? Magrin S; Craxì A; Fiorentino G; Fabiano C; Provenzano G; Pinzello GB; Palazzo U; Almasio P; Pagliaro L J Hepatol; 1991 Jul; 13(1):56-60. PubMed ID: 1717543 [TBL] [Abstract][Full Text] [Related]
9. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV. Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305 [TBL] [Abstract][Full Text] [Related]
10. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Nishiguchi S; Kuroki T; Ueda T; Fukuda K; Takeda T; Nakajima S; Shiomi S; Kobayashi K; Otani S; Hayashi N Ann Intern Med; 1992 Jan; 116(1):21-5. PubMed ID: 1309200 [TBL] [Abstract][Full Text] [Related]
11. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis. Czaja AJ; Magrin S; Fabiano C; Fiorentino G; Diquattro O; Craxi A; Pagliaro L Dig Dis Sci; 1995 Jan; 40(1):33-40. PubMed ID: 7529673 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lenzi M; Johnson PJ; McFarlane IG; Ballardini G; Smith HM; McFarlane BM; Bridger C; Vergani D; Bianchi FB; Williams R Lancet; 1991 Aug; 338(8762):277-80. PubMed ID: 1677111 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders. Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868 [TBL] [Abstract][Full Text] [Related]
15. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States. Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Taswell HF; Homburger HA J Hepatol; 1993 Jul; 18(3):342-52. PubMed ID: 8228128 [TBL] [Abstract][Full Text] [Related]
16. Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients. Thiele DL; DuCharme L; Cunningham MR; Mimms LT; Cuthbert JA; Lee WM; Combes B Am J Gastroenterol; 1996 Feb; 91(2):300-8. PubMed ID: 8607497 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community. Barnes RE; Meyer RA; Gordon SC Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412 [TBL] [Abstract][Full Text] [Related]
18. Frequency and significance of immunoglobulin M antibody to hepatitis B core antigen in corticosteroid-treated severe chronic active hepatitis B. Czaja AJ; Shiels MT; Taswell HF; Wood JR; Ludwig J; Chase RC Mayo Clin Proc; 1988 Feb; 63(2):119-25. PubMed ID: 3339905 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of the antibody to the putative core protein of hepatitis C virus in patients with chronic liver disease. Manzini P; Calvo PL; Brunetto MR; Baldi M; Abate ML; Oliveri F; Negro F; Balzola F; Saracco G; Verme G Liver; 1993 Aug; 13(4):222-6. PubMed ID: 7690874 [TBL] [Abstract][Full Text] [Related]
20. In vitro secretion of anti-GOR protein and anti-hepatitis C virus antibodies in patients with chronic hepatitis C. Löhr HF; Gerken G; Michel G; Braun HB; Meyer zum Büschenfelde KH Gastroenterology; 1994 Nov; 107(5):1443-8. PubMed ID: 7523227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]